Urgent needs to accelerate the race for COVID-19 therapeutics.
作者信息
Batista Carolina, Shoham Shmuel, Ergonul Onder, Hotez Peter, Bottazzi Maria Elena, Figueroa J Peter, Gilbert Sarah, Gursel Mayda, Hassanain Mazen, Kang Gagandeep, Kaslow David, Kim Jerome H, Lall Bhavna, Larson Heidi, Naniche Denise, Sheahan Timothy, Wilder-Smith Annelies, Sow Samba O, Yadav Prashant, Strub-Wourgaft Nathalie
机构信息
Médecins Sans Frontières, Rio de Janeiro, Brazil.
Johns Hopkins University School of Medicine, Baltimore, MD, USA.
出版信息
EClinicalMedicine. 2021 May 23;36:100911. doi: 10.1016/j.eclinm.2021.100911. eCollection 2021 Jun.
Abstract
摘要
相似文献
1
Urgent needs to accelerate the race for COVID-19 therapeutics.迫切需要加快新冠病毒治疗方法的研发竞赛。
EClinicalMedicine. 2021 May 23;36:100911. doi: 10.1016/j.eclinm.2021.100911. eCollection 2021 Jun.
2
CoronaVR: A Computational Resource and Analysis of Epitopes and Therapeutics for Severe Acute Respiratory Syndrome Coronavirus-2.CoronaVR：严重急性呼吸综合征冠状病毒2的表位与治疗方法的计算资源及分析
Front Microbiol. 2020 Jul 31;11:1858. doi: 10.3389/fmicb.2020.01858. eCollection 2020.
3
Unpacking the health and social consequences of COVID-19 through a race, migration and gender lens.通过种族、移民和性别视角剖析新冠疫情的健康与社会影响。
Can J Public Health. 2021 Feb;112(1):8-11. doi: 10.17269/s41997-020-00456-6. Epub 2021 Jan 6.
4
Commentary: Addressing Inequities in the Era of COVID-19: The Pandemic and the Urgent Need for Critical Race Theory.评论：应对新冠疫情时代的不平等现象：大流行与对批判种族理论的迫切需求。
Fam Community Health. 2020 Jul/Sep;43(3):184-186. doi: 10.1097/FCH.0000000000000266.
5
Time to Step Up: A Call to Action For the Clinical and Quantitative Pharmacology Community to Accelerate Therapeutics for COVID-19.加快步伐：呼吁临床和定量药理学界为 COVID-19 加速治疗药物研发。
Clin Transl Sci. 2020 Jul;13(4):646-648. doi: 10.1111/cts.12824. Epub 2020 Jun 11.
6
Reporting and Availability of COVID-19 Demographic Data by US Health Departments (April to October 2020): Observational Study.美国卫生部门对2019冠状病毒病人口数据的报告与可得性（2020年4月至10月）：观察性研究
JMIR Public Health Surveill. 2021 Apr 6;7(4):e24288. doi: 10.2196/24288.
7
Assessing the Impact of a Rapidly Scaled Virtual Urgent Care in New York City During the COVID-19 Pandemic.评估 COVID-19 大流行期间纽约市快速扩展的虚拟紧急护理的影响。
J Emerg Med. 2020 Oct;59(4):610-618. doi: 10.1016/j.jemermed.2020.06.041. Epub 2020 Jun 12.
8
Antiviral Drug Discovery To Address the COVID-19 Pandemic.抗病毒药物研发应对 COVID-19 大流行。
mBio. 2020 Sep 25;11(5):e02134-20. doi: 10.1128/mBio.02134-20.
9
Responding to Health Care Professionals' Mental Health Needs During COVID-19 Through the Rapid Implementation of Project ECHO.通过快速实施ECHO项目应对新冠疫情期间医疗保健专业人员的心理健康需求
J Contin Educ Health Prof. 2020 Summer;40(3):211-214. doi: 10.1097/CEH.0000000000000311.
10
Better the drug you know: Commentary on "Daughton 2020, Natural experiment concept to accelerate the re-purposing of existing therapeutics for Covid-19".
Glob Epidemiol. 2020 Nov;2:100027. doi: 10.1016/j.gloepi.2020.100027. Epub 2020 May 18.
引用本文的文献
1
In silico screening and evaluation of antiviral peptides as inhibitors against ORF9b protein of SARS-CoV-2.针对严重急性呼吸综合征冠状病毒2（SARS-CoV-2）的ORF9b蛋白，进行抗病毒肽作为抑制剂的计算机筛选和评估。
3 Biotech. 2024 Sep;14(9):192. doi: 10.1007/s13205-024-04032-4. Epub 2024 Aug 6.
2
Predicting onset risk of COVID-19 symptom to support healthy travel route planning in the new normal of long-term coexistence with SARS-CoV-2.预测新冠病毒病症状的发病风险，以支持在与严重急性呼吸综合征冠状病毒2长期共存的新常态下规划健康的旅行路线。
Environ Plan B Urban Anal City Sci. 2023 Jun;50(5):1212-1227. doi: 10.1177/23998083221127703. Epub 2022 Sep 17.
3
Mercapto-pyrimidines are reversible covalent inhibitors of the papain-like protease (PLpro) and inhibit SARS-CoV-2 (SCoV-2) replication.巯基嘧啶是木瓜蛋白酶样蛋白酶（PLpro）的可逆共价抑制剂，可抑制严重急性呼吸综合征冠状病毒2（SCoV-2）的复制。
RSC Adv. 2023 Jun 12;13(26):17667-17677. doi: 10.1039/d3ra01915b. eCollection 2023 Jun 9.
4
Treating COVID-19: Targeting the Host Response, Not the Virus.治疗新冠病毒病：针对宿主反应，而非病毒。
Life (Basel). 2023 Mar 6;13(3):712. doi: 10.3390/life13030712.
5
Health-Promoting Behaviors among Older Adults with Noncommunicable Diseases in Rural and Urban Areas during the New Normal Post-COVID-19 Era: A Structural Equation Modeling Analysis.《后新冠疫情时代新常态下农村和城市中老年非传染性疾病患者的健康促进行为：结构方程模型分析》
Nutrients. 2022 Dec 25;15(1):101. doi: 10.3390/nu15010101.
6
Ribavirin aerosol in hospitalized adults with respiratory distress and COVID-19: An open-label trial.利巴韦林气雾剂治疗呼吸窘迫和 COVID-19 的住院成人患者：一项开放标签试验。
Clin Transl Sci. 2023 Jan;16(1):165-174. doi: 10.1111/cts.13436. Epub 2022 Nov 3.
7
Addressing the 'hypoxia paradox' in severe COVID-19: literature review and report of four cases treated with erythropoietin analogues.解决重症 COVID-19 中的“缺氧悖论”：文献回顾和四例接受促红细胞生成素类似物治疗的病例报告。
Mol Med. 2021 Sep 26;27(1):120. doi: 10.1186/s10020-021-00381-5.
本文引用的文献
1
Medical oxygen crisis: a belated COVID-19 response.医用氧气危机：对新冠疫情的迟来应对。
Lancet. 2021 Mar 6;397(10277):868-869. doi: 10.1016/S0140-6736(21)00561-4.
2
Effect of Ivermectin on Time to Resolution of Symptoms Among Adults With Mild COVID-19: A Randomized Clinical Trial.伊维菌素对轻症 COVID-19 成人症状缓解时间的影响：一项随机临床试验。
JAMA. 2021 Apr 13;325(14):1426-1435. doi: 10.1001/jama.2021.3071.
3
What happens in Brazil? A pandemic of misinformation that culminates in an endless disease burden.巴西发生了什么？一场虚假信息的大流行，最终导致无尽的疾病负担。
Rev Soc Bras Med Trop. 2020 Dec 21;54:e07132020. doi: 10.1590/0037-8682-0713-2020. eCollection 2020.
4
Therapeutically administered ribonucleoside analogue MK-4482/EIDD-2801 blocks SARS-CoV-2 transmission in ferrets.治疗性给予核苷类似物 MK-4482/EIDD-2801 可阻断雪貂体内的 SARS-CoV-2 传播。
Nat Microbiol. 2021 Jan;6(1):11-18. doi: 10.1038/s41564-020-00835-2. Epub 2020 Dec 3.
5
A living WHO guideline on drugs for covid-19.关于新冠病毒药物的世界卫生组织实用指南。
BMJ. 2020 Sep 4;370:m3379. doi: 10.1136/bmj.m3379.
6
Against pandemic research exceptionalism.反对大流行研究例外论。
Science. 2020 May 1;368(6490):476-477. doi: 10.1126/science.abc1731. Epub 2020 Apr 23.
Zotero 插件